Melissa Armstrong, MD, MSc, FAAN
BJ And Eve Wilder Professorship In Alzheimer's Disease, Associate Professor Of Neurology, Director, Mangurian Clinical-Research Headquarters For Lewy Body Dementia
Department:
MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone:
(352) 273-5550
Business Email:
melissa.armstrong@neurology.ufl.edu
About Melissa Armstrong
My name is Melissa Armstrong, MD, MSc, and I am the Director of the UF Health Mangurian Clinical-Research Headquarters for Lewy body Dementia at the Norman Fixel Institute for Neurological Diseases.
I received my medical degree from Loyola University Chicago Stritch School of Medicine and later completed my neurology residency there. Following my residency, I completed my movement disorders fellowship at Toronto Western Hospital and my Master of Science in clinical epidemiology and healthcare research at the University of Toronto, both in 2011.
Patients see me for various conditions in the Parkinson family, such as Parkinson disease, Lewy body dementia, and the atypical parkinsonisms (corticobasal syndrome, progressive supranuclear palsy, and multiple system atrophy.
My goal is to partner with people living with these conditions and their families to determine the best approaches for each unique person. Care is driven by the goals of the person living with the condition and their support network.
While there are no cures for these conditions, there are strategies we can take to improve quality of life. I use medications if they will be helpful, work with our amazing therapy, dietary, and social work team members to find non-drug approaches and discuss what to expect in the future.
With funding from the National Institutes of Health (NIH) and the Florida Department of Health, I also conduct research at my lab, the LBD Life Lab, on the lived experiences of people living with parkinsonisms and dementia and their care partners and caregivers.
My research includes investigating causes and outcomes of hospitalization in Lewy body dementia; studying how clinicians, individuals with memory problems, and caregivers discuss a diagnosis of dementia; finding better ways to diagnose and treat dementia with Lewy bodies; identifying the clinical and research priorities of people living with dementia with Lewy bodies and their caregivers; and learning more about the moderate-advanced stages of dementia with Lewy bodies.
When I’m not working with patients and families or conducting research in clinic, I am the Associate Chair of Faculty Development for the Department of Neurology at the University of Florida. In my free time, I enjoy spending time with my family, sewing and photography.
Accomplishments
Faculty Clinical Research Award
2016
·
University of Florida Department of Neurology
Golden Hammer Award
2015
·
University of Maryland Department of Neurology
American Academy of Neurology Emerging Leader
2013
·
American Academy of Neurology
Teaching Profile
Courses Taught
2021
MDC7800 Neurology Clerkship
Board Certifications
-
NeurologyAmerican Board of Psychiatry and Neurology
Clinical Profile
Specialties
- Neurology
Areas of Interest
- Dementia
- Parkinson disease
- Secondary parkinsonism
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-2163-1907
Publications
2024
Best Practices for Communicating a Diagnosis of Dementia
Neurology Clinical Practice.
14(1)
[DOI] 10.1212/cpj.0000000000200223.
2024
Caregiver Experiences and Burden in Moderate-Advanced Dementia With Lewy Bodies
Neurology Clinical Practice.
14(3)
[DOI] 10.1212/cpj.0000000000200292.
2024
Diffusion MRI relates to plasma Aβ42/40 in PET negative participants without dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association.
[DOI] 10.1002/alz.13693.
[PMID] 38441274.
2024
Longitudinal Free‐Water Changes in Dementia with Lewy Bodies
Movement Disorders.
[DOI] 10.1002/mds.29763.
2024
OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson’s disease
Parkinsonism & Related Disorders.
123
[DOI] 10.1016/j.parkreldis.2024.106070.
2024
Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies.
Alzheimer's & dementia : the journal of the Alzheimer's Association.
[DOI] 10.1002/alz.13745.
[PMID] 38400528.
2024
Persons living with dementia and caregivers’ communication preferences for receiving a dementia diagnosis.
PEC innovation.
4
[DOI] 10.1016/j.pecinn.2024.100253.
[PMID] 38298558.
2024
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors.
Journal of Alzheimer's disease : JAD.
97(4):1571-1580
[DOI] 10.3233/JAD-231177.
[PMID] 38277299.
2023
A late-onset neurological disorder: Is progression inevitable? Expert Commentary
Parkinsonism & Related Disorders.
108
[DOI] 10.1016/j.parkreldis.2023.105321.
2023
A systematic scoping review of patient and caregiver self-report measures of satisfaction with clinicians’ communication.
Patient education and counseling.
117
[DOI] 10.1016/j.pec.2023.107976.
[PMID] 37738791.
2023
Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology.
Neurology.
101(19):842-852
[DOI] 10.1212/WNL.0000000000207757.
[PMID] 37495380.
2023
Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson’s Disease Psychosis
Movement Disorders Clinical Practice.
10(3):406-414
[DOI] 10.1002/mdc3.13652.
[PMID] 36949798.
2023
Predicting Progression to Clinical Alzheimer’s Disease Dementia Using the Random Survival Forest.
Journal of Alzheimer's disease : JAD.
95(2):535-548
[DOI] 10.3233/JAD-230208.
[PMID] 37545237.
2023
Prodromal Dementia with Lewy Bodies: A Case Series of the 3 Prodromal Types from Clinical Practice.
Case reports in neurology.
15(1):199-206
[DOI] 10.1159/000533378.
[PMID] 37933327.
2023
Sex differences in dementia with Lewy bodies: Focused review of available evidence and future directions.
Parkinsonism & related disorders.
107
[DOI] 10.1016/j.parkreldis.2023.105285.
[PMID] 36682958.
2022
Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus: A Report of the AAN Guidelines Subcommittee.
Neurology.
98(15):619-631
[DOI] 10.1212/WNL.0000000000200176.
[PMID] 35197360.
2022
Barriers and Best Practices in Disclosing a Dementia Diagnosis: A Clinician Interview Study
Health Services Insights.
15
[DOI] 10.1177/11786329221141829.
[PMID] 36506598.
2022
Clinician approaches to communicating a dementia diagnosis: An interview study.
PloS one.
17(4)
[DOI] 10.1371/journal.pone.0267161.
[PMID] 35421205.
2022
Identifying Parkinson Risk Markers in Primary Care-Old Associations and New Insights.
JAMA neurology.
79(4):331-333
[DOI] 10.1001/jamaneurol.2021.5542.
[PMID] 35254404.
2022
Informal caregiver experiences at the end-of-life of individuals living with dementia with Lewy bodies: An interview study
Dementia.
21(1):287-303
[DOI] 10.1177/14713012211038428.
2022
Lewy Body Dementias: Controversies and Drug Development.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.
19(1):55-67
[DOI] 10.1007/s13311-021-01161-z.
[PMID] 34859379.
2022
Neuropathological and Clinical Correlates of Lewy Body Disease Survival by Race and Ethnicity in the National Alzheimer’s Coordinating Center.
Journal of Alzheimer's disease : JAD.
89(4):1339-1349
[DOI] 10.3233/JAD-220297.
[PMID] 36031892.
2022
Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review.
Alzheimer disease and associated disorders.
36(1):64-72
[DOI] 10.1097/WAD.0000000000000473.
[PMID] 34393189.
2022
Patient values in healthcare decision making among diverse older adults.
Patient education and counseling.
105(5):1115-1122
[DOI] 10.1016/j.pec.2021.08.031.
[PMID] 34509339.
2022
Predictors of Mortality in Individuals with Dementia in the National Alzheimer’s Coordinating Center.
Journal of Alzheimer's disease : JAD.
86(4):1935-1946
[DOI] 10.3233/JAD-215587.
[PMID] 35253760.
2022
Suicidal Ideation and Suicide-Attempt-Related Hospitalizations among People with Alzheimer’s Disease (AD) and AD-Related Dementias in the United States during 2016–2018
Journal of Clinical Medicine.
11(4)
[DOI] 10.3390/jcm11040943.
[PMID] 35207214.
2021
Advances in dementia with Lewy bodies
Therapeutic Advances in Neurological Disorders.
14
[DOI] 10.1177/17562864211057666.
[PMID] 34840608.
2021
Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment.
Frontiers in aging neuroscience.
13
[DOI] 10.3389/fnagi.2021.758298.
[PMID] 34950021.
2021
Biomarker Use for Dementia With Lewy Body Diagnosis: Survey of US Experts.
Alzheimer disease and associated disorders.
35(1):55-61
[DOI] 10.1097/WAD.0000000000000414.
[PMID] 33009039.
2021
Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers: An Interview Study.
Alzheimer disease and associated disorders.
35(4):327-334
[DOI] 10.1097/WAD.0000000000000459.
[PMID] 34034295.
2021
Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis.
Journal of managed care & specialty pharmacy.
27(6):785-790
[DOI] 10.18553/jmcp.2021.27.6.785.
[PMID] 34057395.
2021
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.
Neurology.
97(20):942-957
[DOI] 10.1212/WNL.0000000000012868.
[PMID] 34782410.
2021
Frequency of suicidal ideation and associated clinical features in Lewy body dementia
Parkinsonism & Related Disorders.
90:33-37
[DOI] 10.1016/j.parkreldis.2021.07.029.
2021
Impact of Off Periods on Persons With Parkinson Disease and Care Partners: A Qualitative Study.
Neurology. Clinical practice.
11(3):e232-e238
[DOI] 10.1212/CPJ.0000000000000921.
[PMID] 34484896.
2021
Mapping Actuarial Criteria for Parkinson’s Disease-Mild Cognitive Impairment onto Data-Driven Cognitive Phenotypes
Brain Sciences.
12(1)
[DOI] 10.3390/brainsci12010054.
[PMID] 35053799.
2021
Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset.
Journal of geriatric psychiatry and neurology.
[DOI] 10.1177/08919887211023586.
[PMID] 34114509.
2021
Protocol for an observational cohort study identifying factors predicting accurately end of life in dementia with Lewy bodies and promoting quality end-of-life experiences: the PACE-DLB study
BMJ Open.
11(5)
[DOI] 10.1136/bmjopen-2020-047554.
[PMID] 34039578.
2021
Response to Telemedicine Visits From Patients With Parkinsonism During the COVID-19 Pandemic on Postvisit Surveys.
Journal of patient experience.
8
[DOI] 10.1177/2374373521997224.
[PMID] 34179388.
2021
Strategies to Improve Clinician-Patient Communication Experiences for Patients With Neurologic Conditions.
Neurology. Clinical practice.
11(6):e896-e900
[DOI] 10.1212/CPJ.0000000000001091.
[PMID] 34992974.
2021
Suicide and Lewy body dementia: Report of a Lewy body dementia association working group
International Journal of Geriatric Psychiatry.
36(3):373-382
[DOI] 10.1002/gps.5462.
2021
The inconsistency and instability of Parkinson’s disease motor subtypes.
Parkinsonism & related disorders.
88:13-18
[DOI] 10.1016/j.parkreldis.2021.05.016.
[PMID] 34091412.
2021
Treatment of Parkinson’s Disease with Cognitive Impairment: Current Approaches and Future Directions
Behavioral Sciences.
11(4)
[DOI] 10.3390/bs11040054.
[PMID] 33920698.
2020
An evidence-based methodology for systematic evaluation of clinical outcome assessment measures for traumatic brain injury
PLOS ONE.
15(12)
[DOI] 10.1371/journal.pone.0242811.
[PMID] 33315925.
2020
Assessment of Parkinson disease quality measures on 12-month patient outcomes.
Neurology. Clinical practice.
10(1):58-64
[DOI] 10.1212/CPJ.0000000000000745.
[PMID] 32190421.
2020
Caregiver-Reported Barriers to Quality End-of-Life Care in Dementia With Lewy Bodies: A Qualitative Analysis
American Journal of Hospice and Palliative Medicine®.
37(9):728-737
[DOI] 10.1177/1049909119897241.
[PMID] 31902223.
2020
Case Report: Globus Pallidus Internus (GPi) Deep Brain Stimulation Induced Keyboard Typing Dysfunction.
Frontiers in human neuroscience.
14
[DOI] 10.3389/fnhum.2020.583441.
[PMID] 33240065.
2020
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
Alzheimer's research & therapy.
12(1)
[DOI] 10.1186/s13195-020-00703-5.
[PMID] 33121510.
2020
Choosing a Parkinson Disease Treatment.
JAMA.
323(14)
[DOI] 10.1001/jama.2020.1224.
[PMID] 32286645.
2020
Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI)
Perioperative Care and Operating Room Management.
20
[DOI] 10.1016/j.pcorm.2020.100092.
[PMID] 32577538.
2020
Dementia with Lewy bodies and Parkinson disease dementia: More different than similar?
Neurology.
94(20):858-859
[DOI] 10.1212/WNL.0000000000009433.
[PMID] 32332128.
2020
Diagnosis and Treatment of Parkinson Disease: A Review.
JAMA.
323(6):548-560
[DOI] 10.1001/jama.2019.22360.
[PMID] 32044947.
2020
Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment.
Journal of Alzheimer's disease : JAD.
77(1):165-174
[DOI] 10.3233/JAD-200395.
[PMID] 32804137.
2020
Experience and Impact of OFF Periods in Parkinson’s Disease: A Survey of Physicians, Patients, and Carepartners.
Journal of Parkinson's disease.
10(1):315-324
[DOI] 10.3233/JPD-191785.
[PMID] 31815702.
2020
How do guideline developers identify, incorporate and report patient preferences? An international cross-sectional survey.
BMC health services research.
20(1)
[DOI] 10.1186/s12913-020-05343-x.
[PMID] 32448198.
2020
How to identify, incorporate and report patient preferences in clinical guidelines: A scoping review
Health Expectations.
23(5):1028-1036
[DOI] 10.1111/hex.13099.
[PMID] 32656807.
2020
Parkinson disease with mild cognitive impairment: Domain-specific cognitive complaints predict dementia.
Acta neurologica Scandinavica.
142(6):585-596
[DOI] 10.1111/ane.13326.
[PMID] 32740919.
2020
Participation and consultation engagement strategies have complementary roles: A case study of patient and public involvement in clinical practice guideline development
Health Expectations.
23(2):423-432
[DOI] 10.1111/hex.13018.
[PMID] 31884708.
2020
Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
94(9):392-404
[DOI] 10.1212/WNL.0000000000009033.
[PMID] 32051244.
2020
Research priorities of caregivers and individuals with dementia with Lewy bodies: An interview study
PLOS ONE.
15(10)
[DOI] 10.1371/journal.pone.0239279.
[PMID] 33027276.
2020
The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease.
JAMA neurology.
77(3):295-297
[DOI] 10.1001/jamaneurol.2019.3983.
[PMID] 31841588.
2020
Time for a New Image of Parkinson Disease.
JAMA neurology.
77(11):1345-1346
[DOI] 10.1001/jamaneurol.2020.2412.
[PMID] 32716484.
2019
Author response: Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research.
Neurology.
92(24)
[DOI] 10.1212/WNL.0000000000007669.
[PMID] 31182516.
2019
Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician Interviews
PLOS ONE.
14(4)
[DOI] 10.1371/journal.pone.0215384.
[PMID] 30998707.
2019
Cause of Death and End‐of‐Life Experiences in Individuals with Dementia with Lewy Bodies
Journal of the American Geriatrics Society.
67(1):67-73
[DOI] 10.1111/jgs.15608.
2019
Causes and outcomes of hospitalization in Lewy body dementia: A retrospective cohort study
Parkinsonism & Related Disorders.
64:106-111
[DOI] 10.1016/j.parkreldis.2019.03.014.
2019
Cognitive Complaints in Nondemented Parkinson’s Disease Patients and Their Close Contacts do not Predict Worse Cognitive Outcome.
Alzheimer disease and associated disorders.
33(2):147-153
[DOI] 10.1097/WAD.0000000000000301.
[PMID] 30958414.
2019
Communication About OFF Periods in Parkinson’s Disease: A Survey of Physicians, Patients, and Carepartners.
Frontiers in neurology.
10
[DOI] 10.3389/fneur.2019.00892.
[PMID] 31481924.
2019
Developing the Disorders of Consciousness Guideline and Challenges of Integrating Shared Decision-Making Into Clinical Practice.
The Journal of head trauma rehabilitation.
34(3):199-204
[DOI] 10.1097/HTR.0000000000000496.
[PMID] 31058760.
2019
End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers
PLOS ONE.
14(5)
[DOI] 10.1371/journal.pone.0217039.
[PMID] 31145749.
2019
Improving patient‐centred care for persons with Parkinson’s: Qualitative interviews with care partners about their engagement in discussions of “off” periods
Health Expectations.
22(3):555-564
[DOI] 10.1111/hex.12884.
[PMID] 30977262.
2019
Lewy Body Dementias.
Continuum (Minneapolis, Minn.).
25(1):128-146
[DOI] 10.1212/CON.0000000000000685.
[PMID] 30707190.
2019
Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET Testing.
Alzheimer disease and associated disorders.
33(3):246-253
[DOI] 10.1097/WAD.0000000000000311.
[PMID] 31058683.
2019
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
93(13):584-594
[DOI] 10.1212/WNL.0000000000008157.
[PMID] 31462584.
2019
Recognizing and treating atypical Parkinson disorders.
Handbook of clinical neurology.
167:301-320
[DOI] 10.1016/B978-0-12-804766-8.00016-9.
[PMID] 31753139.
2019
Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson’s Disease.
Dementia and geriatric cognitive disorders.
47(4-6):187-197
[DOI] 10.1159/000496454.
[PMID] 31315127.
2019
Shared decision making in mild cognitive impairment.
Neurology. Clinical practice.
9(2):160-164
[DOI] 10.1212/CPJ.0000000000000576.
[PMID] 31041132.
2019
Tackling the imposter phenomenon to advance women in neurology.
Neurology. Clinical practice.
9(2):155-159
[DOI] 10.1212/CPJ.0000000000000607.
[PMID] 31041131.
2019
The Clinician Guideline Determinants Questionnaire was developed and validated to support tailored implementation planning.
Journal of clinical epidemiology.
113:129-136
[DOI] 10.1016/j.jclinepi.2019.05.024.
[PMID] 31152863.
2019
The experience of off periods: Qualitative analysis of interviews with persons with Parkinson’s and carepartners.
Clinical parkinsonism & related disorders.
1:31-36
[DOI] 10.1016/j.prdoa.2019.07.008.
[PMID] 34316596.
2019
Virtual Support Groups for Informal Caregivers of Individuals With Dementia: A Scoping Review.
Alzheimer disease and associated disorders.
33(4):362-369
[DOI] 10.1097/WAD.0000000000000349.
[PMID] 31567144.
2018
Approach to assessing and using clinical practice guidelines.
Neurology. Clinical practice.
8(1):58-61
[DOI] 10.1212/CPJ.0000000000000417.
[PMID] 29517067.
2018
Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
91(8):373-374
[DOI] 10.1212/WNL.0000000000006042.
[PMID] 30126885.
2018
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
90(10):464-471
[DOI] 10.1212/WNL.0000000000005055.
[PMID] 29440566.
2018
Comprehensive Systematic Review Update Summary: Disorders of Consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research.
Archives of physical medicine and rehabilitation.
99(9):1710-1719
[DOI] 10.1016/j.apmr.2018.07.002.
[PMID] 30098792.
2018
Comprehensive systematic review update summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research.
Neurology.
91(10):461-470
[DOI] 10.1212/WNL.0000000000005928.
[PMID] 30089617.
2018
Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
91(20):923-933
[DOI] 10.1212/WNL.0000000000006502.
[PMID] 30315070.
2018
Identifying priority outcomes that influence selection of disease-modifying therapies in MS.
Neurology. Clinical practice.
8(3):179-185
[DOI] 10.1212/CPJ.0000000000000449.
[PMID] 30105155.
2018
Impact of patient involvement on clinical practice guideline development: a parallel group study
Implementation Science.
13(1)
[DOI] 10.1186/s13012-018-0745-6.
[PMID] 29661195.
2018
Practice guideline update recommendations summary: Disorders of consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research.
Neurology.
91(10):450-460
[DOI] 10.1212/WNL.0000000000005926.
[PMID] 30089618.
2018
Practice Guideline Update Recommendations Summary: Disorders of Consciousness: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology; the American Congress of Rehabilitation Medicine; and the National Institute on Disability, Independent Living, and Rehabilitation Research.
Archives of physical medicine and rehabilitation.
99(9):1699-1709
[DOI] 10.1016/j.apmr.2018.07.001.
[PMID] 30098791.
2018
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
90(3):126-135
[DOI] 10.1212/WNL.0000000000004826.
[PMID] 29282327.
2018
Progressive Supranuclear Palsy: an Update.
Current neurology and neuroscience reports.
18(3)
[DOI] 10.1007/s11910-018-0819-5.
[PMID] 29455271.
2018
Understanding, Impact, and Communication of “Off” Periods in Parkinson’s Disease: A Scoping Review.
Movement disorders clinical practice.
5(5):461-470
[DOI] 10.1002/mdc3.12672.
[PMID] 30515435.
2017
Author response: Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
88(24):2337-2338
[DOI] 10.1212/WNL.0000000000004047.
[PMID] 28607140.
2017
Dementia with Lewy bodies advances: A new consensus report.
Neurology.
89(1):18-19
[DOI] 10.1212/WNL.0000000000004071.
[PMID] 28592452.
2017
Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson Disease
Journal of Geriatric Psychiatry and Neurology.
30(4):191-195
[DOI] 10.1177/0891988717710335.
2017
Framework for enhancing clinical practice guidelines through continuous patient engagement.
Health expectations : an international journal of public participation in health care and health policy.
20(1):3-10
[DOI] 10.1111/hex.12467.
[PMID] 27115476.
2017
Hospitalization and Rehospitalization in Parkinson Disease Patients: Data From the National Parkinson Foundation Centers of Excellence
PLoS One.
12(7)
[DOI] 10.1371/purnal.pone.0180425.
2017
Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.
PloS one.
12(7)
[DOI] 10.1371/journal.pone.0180425.
[PMID] 28683150.
2017
Improving email strategies to target stress and productivity in clinical practice.
Neurology. Clinical practice.
7(6):512-517
[DOI] 10.1212/CPJ.0000000000000395.
[PMID] 29431178.
2017
Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey.
BMC medical informatics and decision making.
17(1)
[DOI] 10.1186/s12911-016-0404-2.
[PMID] 28086771.
2017
Patient involvement in guidelines is poor five years after institute of medicine standards: review of guideline methodologies.
Research involvement and engagement.
3
[DOI] 10.1186/s40900-017-0070-2.
[PMID] 29062544.
2017
Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitation: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
88(22):2141-2149
[DOI] 10.1212/WNL.0000000000003966.
[PMID] 28490655.
2017
Recommendations for patient engagement in guideline development panels: A qualitative focus group study of guideline-naïve patients
PLOS ONE.
12(3)
[DOI] 10.1371/journal.pone.0174329.
[PMID] 28319201.
2017
Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.
Neurology. Clinical practice.
7(3):189-190
[DOI] 10.1212/01.CPJ.0000520916.56328.f5.
[PMID] 30128173.
2017
Response shift – The experience of disease progression in Parkinson disease.
Parkinsonism & related disorders.
36:52-56
[DOI] 10.1016/j.parkreldis.2016.12.027.
[PMID] 28082015.
2017
Shared decision-making in stroke: an evolving approach to improved patient care
Stroke and Vascular Neurology.
2(2):84-87
[DOI] 10.1136/svn-2017-000081.
[PMID] 28959495.
2017
The Case for Antipsychotics in Dementia with Lewy Bodies.
Movement disorders clinical practice.
4(1):32-35
[DOI] 10.1002/mdc3.12383.
[PMID] 30713945.
2017
Use of theory to plan or evaluate guideline implementation among physicians: a scoping review.
Implementation science : IS.
12(1)
[DOI] 10.1186/s13012-017-0557-0.
[PMID] 28241771.
2017
Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
20(2):292-295
[DOI] 10.1016/j.jval.2016.11.008.
[PMID] 28237212.
2016
Augmented Restless Legs Syndrome with Marked Hyperkinesias and Impulsive-Compulsive Behaviors.
Movement disorders clinical practice.
3(4):412-414
[DOI] 10.1002/mdc3.12299.
[PMID] 30713933.
2016
Patient engagement and shared decision-making: What do they look like in neurology practice?
Neurology. Clinical practice.
6(2):190-197
[PMID] 27104070.
2016
Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
87(24):2585-2593
[PMID] 27856776.
2016
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Neurology.
86(19):1818-26
[DOI] 10.1212/WNL.0000000000002560.
[PMID] 27164716.
2016
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
87(6)
[DOI] 10.1212/01.wnl.0000491123.28224.44.
[PMID] 27502965.
2015
Does spouse participation influence quality of life reporting in patients with Parkinson’s disease?
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.
24(1):245-9
[DOI] 10.1007/s11136-014-0744-2.
[PMID] 24972974.
2015
Extracorporeal membrane oxygenation: uncommon cause of corpus callosal microhemorrhage.
Neurology.
84(6)
[DOI] 10.1212/WNL.0000000000001227.
[PMID] 25666630.
2015
Independent application of montreal cognitive assessment/mini-mental state examination conversion.
Movement disorders : official journal of the Movement Disorder Society.
30(12):1710-1
[DOI] 10.1002/mds.26221.
[PMID] 25820874.
2015
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology.
85(21):1896-903
[DOI] 10.1212/WNL.0000000000002146.
[PMID] 26598432.
2014
“Rapidly” Progressive Supranuclear Palsy.
Movement disorders clinical practice.
1(1):70-72
[DOI] 10.1002/mdc3.12011.
[PMID] 30363883.
2014
Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson’s Disease?
Movement disorders clinical practice.
1(1):67-69
[DOI] 10.1002/mdc3.12009.
[PMID] 30363792.
2014
Diagnosis and treatment of corticobasal degeneration.
Current treatment options in neurology.
16(3)
[DOI] 10.1007/s11940-013-0282-1.
[PMID] 24469408.
2014
Improved methods for capture, extraction, and quantitative assay of environmental DNA from Asian bigheaded carp (Hypophthalmichthys spp.).
PloS one.
9(12)
[DOI] 10.1371/journal.pone.0114329.
[PMID] 25474207.
2014
Which features of Parkinson’s disease predict earlier exit from the workforce?
Parkinsonism & related disorders.
20(11):1257-9
[DOI] 10.1016/j.parkreldis.2014.08.005.
[PMID] 25179494.
2013
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.
Journal of neurology, neurosurgery, and psychiatry.
84(2):130-5
[DOI] 10.1136/jnnp-2012-302684.
[PMID] 22933817.
2013
Clinicopathological review of pallidonigroluysian atrophy.
Movement disorders : official journal of the Movement Disorder Society.
28(3):274-81
[DOI] 10.1002/mds.25232.
[PMID] 23114877.
2013
Criteria for the diagnosis of corticobasal degeneration.
Neurology.
80(5):496-503
[DOI] 10.1212/WNL.0b013e31827f0fd1.
[PMID] 23359374.
2013
Impact of mild cognitive impairment on health-related quality of life in Parkinson’s disease.
Dementia and geriatric cognitive disorders.
36(1-2):67-75
[DOI] 10.1159/000350032.
[PMID] 23774742.
2013
Measuring mild cognitive impairment in patients with Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society.
28(5):626-33
[DOI] 10.1002/mds.25426.
[PMID] 23520128.
2013
Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.
Neurology.
80(22):2065-9
[DOI] 10.1212/WNL.0b013e318294b32d.
[PMID] 23713086.
2013
The American Academy of Neurology’s top five choosing wisely recommendations.
Neurology.
81(11):1004-11
[DOI] 10.1212/WNL.0b013e31828aab14.
[PMID] 23430685.
2013
The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson’s disease.
Parkinsonism & related disorders.
19(4):463-5
[DOI] 10.1016/j.parkreldis.2012.09.005.
[PMID] 23036511.
2012
Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.
Neurology.
79(6):597-603
[DOI] 10.1212/WNL.0b013e318263c443.
[PMID] 22815556.
2012
Improvement of apathy after levofloxacin treatment: an N-of-1 study.
The neurologist.
18(3):146-8
[DOI] 10.1097/NRL.0b013e318251eb23.
[PMID] 22549356.
2012
Roles of Education and IQ in Cognitive Reserve in Parkinson’s Disease-Mild Cognitive Impairment.
Dementia and geriatric cognitive disorders extra.
2(1):343-52
[DOI] 10.1159/000341782.
[PMID] 22962558.
2012
The pill questionnaire in a nondemented Parkinson’s disease population.
Movement disorders : official journal of the Movement Disorder Society.
27(10):1308-11
[DOI] 10.1002/mds.25124.
[PMID] 22865587.
2011
Expanding the phenomenology of benign hereditary chorea: evolution from chorea to myoclonus and dystonia.
Movement disorders : official journal of the Movement Disorder Society.
26(12):2296-7
[DOI] 10.1002/mds.23822.
[PMID] 21714005.
2009
Cerebroretinal microangiopathy with calcifications and cysts: demonstration of radiological progression.
Journal of computer assisted tomography.
33(4):571-2
[DOI] 10.1097/RCT.0b013e31818c0957.
[PMID] 19638852.
2006
Discontinuation of perioperative antiplatelet and anticoagulant therapy in stroke patients.
Neurologic clinics.
24(4):607-30
[PMID] 16935191.
2006
Thoracic intramedullary cavernous malformation with posttraumatic hematomyelia: case report and literature review.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
15(2):74-8
[PMID] 17904054.
Grants
Jan 2023
ACTIVE
CTOA Armstrong – Residuals ?
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Jun 2022
– Jul 2023
Neurodegeneration and Neuronal Fluctuations in DLB and AD
Role: Other
Funding: NATL INST OF HLTH NIA
Mar 2022
ACTIVE
Smartphone phenotype collection for diagnostic screening of mild cognitive impairment
Role: Principal Investigator
Funding: PARABON NANOLABS
via NATL INST OF HLTH NIA
Feb 2022
ACTIVE
Higher Order Convolutional Neural Network for Classification of Lewy-body Diseases and Alzheimers Disease
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS
Sep 2021
ACTIVE
Multi-Stakeholder Engagement for Interdisciplinary Telehealth in Lewy Body Dementia
Role: Other
Funding: NATL INST OF HLTH NIA
Jan 2021
– Dec 2022
Characterizing Cognitive Fluctuations in Lewy Body Dementia to Improve Care and Research
Role: Other
Funding: UF FOUNDATION
Jan 2021
– Jun 2022
Delirium-onset Lewy body biomarkers
Role: Other
Funding: UF FOUNDATION
Sep 2020
ACTIVE
Identifying Factors Predicting ACcurately End-of-Life in Dementia with Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
Role: Principal Investigator
Funding: NATL INST OF HLTH NIA
Sep 2020
– Sep 2022
F022983 – UF Parkinson's Disease/Movement Disorders Fund
Role: Principal Investigator
Funding: UF FOUNDATION
Sep 2020
– May 2023
PATIENT EXPERIENCES WITH PARKINSONS DISEASE TREATMENTS: A MIXED-METHODS STUDY
Role: Principal Investigator
Funding: CEREVEL THERAPEUTICS
Aug 2020
ACTIVE
Interdisciplinary Training in Movement Disorders and Neurorestoration
Role: Principal Investigator
Funding: NATL INST OF HLTH NINDS
Jun 2020
ACTIVE
1Florida Alzheimers Disease Research Center
Role: Co-Investigator
Funding: NATL INST OF HLTH NIA
May 2020
– Apr 2023
Communication of Dementia Diagnoses: Investigating Patient, Family, and Physician Experiences and Developing Best Practices
Role: Principal Investigator
Funding: FL DEPT OF HLTH ED ETHEL MOORE ALZHEIMER
Feb 2020
– May 2020
Prevalence and Demographics of Multiple Sclerosis in the OneFlorida Data Trust
Role: Other
Funding: NATL MULTIPLE SCLEROSIS SOC
Jan 2020
– Jun 2022
Lewy Body Dementia: Mangurian
Role: Principal Investigator
Funding: UF FOUNDATION
Oct 2019
ACTIVE
LBDA RCOE Program
Role: Principal Investigator
Funding: LEWY BODY DEMENTIA ASSOC
Oct 2018
– Sep 2019
University of Florida Collaboration as LBDA Research Center of Excellence- Year 2
Role: Principal Investigator
Funding: LEWY BODY DEMENTIA ASSOC
Jul 2018
– Jun 2020
Investigating Patterns of Care for Dementia with Lewy Bodies in Florida
Role: Other
Funding: AMER ACAD OF NEUROLOGY
Oct 2017
– Sep 2018
University of Florida Collaboration as LBDA Research Center of Excellence
Role: Principal Investigator
Funding: LEWY BODY DEMENTIA ASSOC
Sep 2015
– Jun 2020
Enhancing Clinical Guideline Development via Patient and Stakeholder
Role: Principal Investigator
Funding: AGENCY FOR HEALTHCARE RES AND QUALITY
Aug 2015
– May 2021
University of Florida – Mt. Sinai Medical Center AD Research Center
Role: Project Manager
Funding: NATL INST OF HLTH NIA
Education
MD
2003
·
Loyola University Medical Center
Contact Details
Phones:
- Business:
- (352) 273-5550
Emails:
- Business:
- melissa.armstrong@neurology.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100268
GAINESVILLE FL 32611 - Business Street:
-
3011 SW WILLISTON RD RM 1103
GAINESVILLE FL 32608